We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAVN:NASDAQNavan, Inc. Analysis

Data as of 2026-05-19 - not real-time

$18.92

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Navan, Inc. (NAVN) is trading at $18.92, comfortably above its 20‑day ($17.64), 50‑day ($14.03) and 200‑day ($14.13) simple moving averages, indicating short‑term price strength, but the Relative Strength Index of 71.5 places the stock in overbought territory and the MACD histogram is negative, signaling a bearish momentum shift. Support sits near $14.53 while resistance is around $19.40, and the current price is edging close to that ceiling amid an increasing volume trend and a high 30‑day volatility of 42%, with a beta of 1.09 suggesting slightly higher market risk.
Fundamentally, NAVN posted a 34.8% revenue surge to $702 M and maintains a strong gross margin of 71%, yet operating and net margins are deeply negative (‑45% and ‑57% respectively) and EBITDA remains in the red. The company holds $740 M in cash against $174 M of debt, giving a sizable cash runway, while a discounted cash‑flow model values the shares at $22.28, implying roughly 17% upside from the current price. Analyst consensus is a “strong buy” with a median target of $22, but the stock is entangled in multiple securities‑class‑action lawsuits with a looming April 24 deadline, adding legal uncertainty to the investment case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicating overbought conditions
  • Bearish MACD histogram
  • Pending securities class‑action litigation

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high gross margin
  • Cash cushion exceeding debt
  • DCF fair value suggests ~17% upside

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Unprofitable operating model requiring turnaround
  • Sustained cash runway but high burn rate
  • Potential for AI‑driven travel platform expansion

Key Metrics & Analysis

Financial Health

Revenue Growth34.80%
Profit Margin-56.68%
P/E Ratio85.3
ROE-60.20%
ROA-8.45%
Debt/Equity14.43
P/B Ratio3.9
Op. Cash Flow$33.7M
Free Cash Flow$142.7M
Industry P/E38.3

Technical Analysis

TrendNeutral
RSI71.5
Support$14.53
Resistance$19.40
MA 20$17.64
MA 50$14.03
MA 200$14.13
MACDBearish
VolumeIncreasing
Fear & Greed Index89.32

Valuation

Fair Value$22.28
Target Price$22.13
Upside/Downside16.98%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.09
Volatility42.37%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.